Correlation Between Senti Biosciences and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Senti Biosciences and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Lipella Pharmaceuticals.
Diversification Opportunities for Senti Biosciences and Lipella Pharmaceuticals
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Senti and Lipella is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Senti Biosciences and Lipella Pharmaceuticals
Given the investment horizon of 90 days Senti Biosciences is expected to generate 0.35 times more return on investment than Lipella Pharmaceuticals. However, Senti Biosciences is 2.82 times less risky than Lipella Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about -0.05 per unit of risk. If you would invest 224.00 in Senti Biosciences on August 29, 2024 and sell it today you would lose (13.00) from holding Senti Biosciences or give up 5.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Senti Biosciences |
| Lipella Pharmaceuticals |
Senti Biosciences and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Lipella Pharmaceuticals
The main advantage of trading using opposite Senti Biosciences and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |